Select from the featured topics below:

Current & Emerging Therapies in Relapsing MS

Mark S. Freedman, HBSc, MSc, MD, CSPQ, FAAN, FRCPC
Ottawa Hospital Research Institute

Biography   Abstract


Peter A. Calabresi, MD
Johns Hopkins University Medical Center

Biography   Abstract


Patricia K. Coyle, MD, FAAN, FANA
Stony Brook University Hospital

Biography   Abstract


Claire S. Riley, MD
Columbia University MS Center

Biography   Abstract


Aliza Ben-Zacharia, PhD, DNP, RN, ANP-BC, MSCN, FAAN
Mount Sinai Health System

Biography   Abstract


Jonathan E. Howard, MD
NYU Health

Biography   Abstract



For questions, contact the CME provider, Postgraduate Institute for Medicine at inquiries@pimed.com or the CNE provider, Letters & Sciences at jmiller@letsci.org

Updates of Late-Breaking
Data & Abstracts


The MS therapeutic repertoire is rapidly expanding as cutting-edge research into the causes of MS is defining intricate and novel immunological and pathological pathways informing drug discovery and therapeutic interventions. As presented at the 2020 Joint ACTRIMS-ECTRIMS Virtual Meeting, outcomes of recent clinical trials of new agents and interventions will be evaluated, as well as disease activity and treatment response biomarkers that are changing the treatment paradigm towards personalized medicine in MS.

Clinical choices are more complex and challenging than ever, offering more treatment options. Providers are challenged to consider treating earlier and to implement advances in technology and new treatment paradigms to optimize treatment outcomes. With focus on the horizon, powerful chemo-ablative agents, together with autologously derived stem cells derived from bone marrow, are aimed to completely eradicating and rebuilding an immune system that is both immunocompetent and tolerant, with the hope of reversing MS.

This CME/CNE activity provides clinicians with insights and information on the latest advances in the treatment of MS. For both general neurologists, MS specialists, neuroscience nurses and other healthcare professionals, a fundamental appreciation of the immunopathology of MS will lead to a better understanding of the disease course and an appreciation of the MS therapeutics that are now, more than ever, tailored to the intricacies of the immune system. This activity also will review family planning and pregnancy, along with the role of mental health professionals in comprehensive MS management.

Each presentation on this website is available for credit. You may visit as a guest; however, you must register prior to taking the posttest to obtain credit. Registration will also allow you to keep track of presentations that you have viewed and to reprint certificates for activities that you have completed.